Roche Pharmaceuticals Omitted Accutane Side Effects in 2009 FDA Filing
As of January 2001, over 5,000 individuals have filed lawsuits against Roche Pharmaceuticals, the makers of Accutane. These lawsuits claim that Accutane caused severe bowel problems, including inflammatory bowel disease, Crohn’s disease, and similar chronic conditions.
Roche Pharmaceuticals took Accutane off the U.S. market in 2009. However, even though the National Institutes of Health and other medical institutions had documented that Accutane use was linked to birth defects, an increased risk of suicide, and bowel disorders, Roche mentioned none of these when it explained to the Food and Drug Administration (FDA) why it was taking Accutane off the market. Instead, Roche merely said that it was discontinuing Accutane because the drug faced too much competition from generics.
As a result, in 2010 the FDA released a statement saying that Roche had given it no reason to believe that Accutane was discontinued for causing medical problems. Roche continues to deny that Accutane causes an increased suicide risk, even though Accutane labels carry this warning.
Several Accutane-related lawsuits have been filed in New Jersey and are set to go to trial this year. We will continue to watch the cases develop to determine what Roche did and did not know about the possible dangers of Accutane use.
If you or a loved one has taken Accutane and now suffers from an inflammatory bowel condition, please don’t hesitate to contact the experienced PA Accutane injury lawyers at Cherry Fieger & Marciano, LLP. We will investigate your case thoroughly and help you seek the compensation you deserve. Call Cherry Fieger & Marciano, LLP today at 888-684-7192 for a free and confidential case evaluation.
